Fmoc-D-Aha-OH

Fmoc-D-Aha-OH is a fluorenylmethoxycarbonyl (Fmoc) protected D-amino acid derivative featuring an α-amino acid backbone and a side chain characteristic of Aha (aminohexanoic acid) chemistry, providing a stereodefined chiral center at the D-configuration. The Fmoc group serves as an N-protecting moiety that is stable to many coupling conditions yet can be removed under standard base-mediated deprotection to regenerate the reactive amine for peptide assembly. The molecule terminates with a free carboxylic acid (-CO2H), enabling direct participation in amide bond formation and downstream transformations typical of protected amino acid building blocks. The combination of an acid functionality, a protected amine, and a chemically accessible aliphatic side chain supports both peptide synthesis compatibility and side-chain derivatization routes used in synthetic organic chemistry and biochemical research.

1. Peptide Synthesis

Fmoc-D-Aha-OH is used in peptide synthesis workflows where D-configured amino acid incorporation is required to control stereochemistry, proteolytic stability, and conformational preferences in peptide sequences. The Fmoc-protected nitrogen enables stepwise solid-phase or solution-phase coupling after base-triggered Fmoc removal, while the free carboxylic acid supports activation and amide bond formation to build peptide chains. The D-stereocenter and aliphatic side chain can be positioned to tune backbone geometry and spacing of functional groups for peptide analog construction. Resulting D-Aha-containing peptides can be applied as research-grade ligands, enzyme substrates, or stability-focused peptide scaffolds, supporting consistent amino acid chemistry from synthesis to analytical characterization.

2. Unnatural Amino Acid Incorporation

Fmoc-D-Aha-OH functions as a chiral building block for unnatural amino acid incorporation in chemical biology and peptide engineering programs that require non-proteinogenic residues. The defined D-configuration provides predictable stereochemical outcomes during coupling, while the Fmoc group maintains orthogonality with many functional group chemistries until deprotection is performed. The free carboxyl group allows conversion into activated derivatives or direct coupling partners, supporting integration into larger peptide frameworks or multicomponent synthesis strategies. Incorporation of D-Aha can be leveraged to generate stereochemically defined analogs for mechanistic studies, structure-activity relationship studies, and scaffold diversification in applied amino acid chemistry.

3. Side-Chain Functionalization

Fmoc-D-Aha-OH is suitable for side-chain functionalization strategies that start from an aliphatic amino acid scaffold and introduce reactive handles for further derivatization. The protected amine and free carboxylic acid enable controlled sequencing of protection/deprotection steps so that side-chain modification can be performed either before peptide incorporation or after installation into a peptide context. The aliphatic Aha side chain can be transformed into functional motifs through standard organic functional group chemistry, supporting generation of conjugation-ready intermediates and peptidomimetic building blocks. Downstream derivatives produced from Fmoc-D-Aha-OH can feed into biomolecule labeling, affinity probe construction, and synthetic intermediate preparation for fine chemical synthesis.

4. Bioconjugation Chemistry

Fmoc-D-Aha-OH can be employed in bioconjugation chemistry as a protected amino acid precursor that enables controlled introduction of a D-amino acid segment into conjugatable peptides and linkers. The Fmoc group supports peptide assembly into defined conjugation backbones, while the carboxylic acid functionality enables formation of stable amide linkages that remain compatible with subsequent conjugation steps. D-Aha-containing linkers can help modulate spacing, local flexibility, and stereochemical presentation of reactive groups used for coupling to proteins, polymers, or detection tags. Resulting conjugation-ready constructs support chemical biology workflows requiring reproducible linker architecture and amino acid stereodefinition for downstream analytical and materials-related studies.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-Aha-OH is applicable to pharmaceutical intermediate preparation where protected amino acid derivatives serve as controlled inputs for peptide-like and peptidomimetic fragments used in process chemistry. The Fmoc-protected amine and free carboxylic acid provide a manufacturable, stereodefined handle for constructing amide bonds under standard peptide coupling conditions, including routes that integrate orthogonal protection logic. The D-configuration can be maintained through synthesis to support consistent stereochemical identity of intermediates used in medicinal chemistry programs and scale-up-oriented fine chemical production. Downstream use includes generation of D-Aha-containing intermediates for SAR studies, fragment elaboration, and controlled synthesis of complex chiral molecules that depend on protected amino acid chemistry.

1. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging